Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin [Phase 3]

View source ↗

Summary

The document reports on a Phase 3 clinical trial evaluating the efficacy and safety of ipragliflozin in adults with type 2 diabetes mellitus inadequately contro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ipragliflozin (ipragliflozin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED